0001415889-23-012621.txt : 20230824 0001415889-23-012621.hdr.sgml : 20230824 20230824180507 ACCESSION NUMBER: 0001415889-23-012621 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230822 FILED AS OF DATE: 20230824 DATE AS OF CHANGE: 20230824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farnum Rhonda CENTRAL INDEX KEY: 0001898490 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 231203238 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 form4-08242023_100801.xml X0508 4 2023-08-22 0001583107 Theravance Biopharma, Inc. TBPH 0001898490 Farnum Rhonda C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 false true false false SVP, COMM & MEDICAL AFFAIRS 1 Ordinary Shares 2023-08-22 4 S 0 1807 9.47 D 340566 D This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023. /s/ Brett A. Grimaud, Attorney-in-Fact 2023-08-24